BioSpace News Archive

Sonoma Pharmaceuticals, Inc., a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, announced that it has launched two new dental products.

Adamis Pharmaceuticals Corporation ) today highlighted that the NIH has identified Tempol as a potential home treatment for COVID-19

NLS Pharmaceutics Ltd., a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application No. 16/083,131.

BriaCell Therapeutics Corp. jointly announces a multi-year, non-exclusive license agreement with ImaginAb Inc

AMO Pharma Limited, a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no treatment options, announced that Alan L. Rubino has joined the AMO Pharma board of directors as chairman as of August 16, 2021.

Galmed Pharmaceuticals Ltd. announced today the publication in The Journal of Autoimmunity for its IND ready compound, Amilo-5MER entitled: “MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.”

AffyImmune Therapeutics, Inc. announced today that scientific co-founder Moonsoo Jin will present twice at Hanson Wade’s 6 th CAR-TCR Summit being held virtually August 30 – September 2 .

PerkinElmer, Inc today announced the launch of its MaxSignal® Mycotoxin Automation Bundle .

Helix BioPharma Corp. today announced that Dr. Krzysztof Saczek has been appointed as a member of the Board of Directors of the Company effective immediately.

Speclipse, a startup specializing in laser spectroscopic and AI-based medical diagnosis technologies and a member of Born2Global Centre, recently attracted USD 7.7 million in investments for an accumulated investment total of USD 13 million.